Byetta Lawyer

Published on July 25, 2013 by Laurie Villanueva

Text-Size:A A A+

If you are a type-2 diabetic who developed pancreatic cancer, pancreatitis or thyroid cancer after taking a medication belonging to a class of drugs known as incretin mimetics, you are strongly urged to contact a Byetta lawyer as soon as possible to potentially file a Byetta lawsuit.

Prompted by a wave of research tying Byetta, along with other incretin mimetics including Januvia to these life-threatening diseases, attorneys at the nationwide law firm of Bernstein Liebhard LLP are actively investigating potential claims on behalf of patients who may have suffered side effects. The Firm is eager to hear from anyone harmed by Byetta, and is offering free and confidential case evaluations to patients who may have a case against an incretin mimetic manufacturer. Call the Firm today at .

A Byetta Lawyer Will Monitor Updates in Growing Investigation of Incretin Mimetics

In working with a Byetta lawyer, you can rest assured that someone is actively following the growing FDA investigation over the safety of Byetta, Januvia and other incretin mimetics on your behalf. The self-injectable medication, which stimulates the pancreas to produce insulin in patients with type 2 diabetes, has been the subject of warnings by the U.S. Food and Drug Administration (FDA) since 2007 and has been involved in numerous studies published in medical journals over the past few years.

The first FDA warning about the connection between Byetta and pancreatitis was issued in October 2007 after 30 users reportedly developed an acute form of the disease. A year later, a second Byetta alert was issued after the agency received 6 more pancreatitis reports that included two deaths.

Symptoms of Byetta pancreatitis include fever, increased heart rate, swelling or tenderness in the abdomen, abdominal pain that radiates into the back, as well as nausea and or vomiting. If you are experiencing any of these ailments, you are strongly urged to call a Byetta lawyer right away.

Byetta and Pancreatic Cancer

Concerns over the link between Byetta and pancreatic cancer have grown significantly in recent years.

In February 2011, concerns about Byetta and pancreatic cancer began to take shape when a study published in Gastroenterology reported that users of the diabetes medication were at a three-fold increased the risk for the disease.

Similar fears were further heightened in March 2013, when the FDA alerted the public that it would be investigating the safety of not only Byetta, but also other incretin mimetics like Januvia after learning of information from an unpublished study revealing the drug’s potential to cause pancreatic duct metaplasia, which is characterized by precancerous changes in the pancreas.

A month before that, a JAMA Internal Medicine study found a patient who took Byetta or Januvia might be at a doubled risk for developing pancreatic cancer. If you are experiencing chills and clammy skin, bloating, abdominal pain, dark urine, fever, sweating, weakness, vomiting or loss of appetite, it is imperative that you phone a doctor immediately. These may be signs of pancreatic cancer caused by Byetta.

FDA Reports Show Nearly 1,000 Pancreatic Side Effect Reports over 1-Year Period

A Byetta study that perhaps sparked some of the most attention, however, was an analysis led by the Institute for Safe Medicine Practices. Released in April 2013, the research looked at adverse event reports filed with the FDA over a 1-year period that ended in June 2012. According to the Institute’s findings, the agency received 263 Byetta pancreatitis reports, as well as 71 reports of Byetta pancreatic cancer and 14 reports of Byetta thyroid cancer.  Over that same period, an incretin mimetic known as Januvia was tied to similar pancreatic side effects.

This class of drugs was associated with more than 800 reports of pancreatitis, 105 cases of pancreatic cancer, and 32 reports of thyroid cancer, the research found.

In light of these findings, the British Medical Journal later raised concerns that incretin mimetic manufacturers downplayed the medications’ pancreatic effects after researchers obtained a large amount of unpublished data through Freedom of Information Act requests revealing an “unwanted proliferative or inflammatory pancreatic effect.”

Working with a Byetta Lawyer at Bernstein Liebhard LLP

Attorneys at our Firm have an impressive track record of successfully representing hundreds of people harmed by dangerous medical devices and drugs. We are committed to ensuring you receive compensation for your pain and suffering.

Since 1993, Bernstein Liebhard LLP lawyers have recovered over $3 billion on behalf of patients harmed by medical products. When you choose one of our attorneys to represent you in your case against the makers of Byetta, you will have a diligent and highly experienced team of lawyers, investigators and paralegals all working together to protect your legal rights and obtain a physical, emotional and financial recovery. For a free and confidential case evaluation, contact the Firm at .